Company intelligence / Profile preview

Faber Daeufer & Itrato

Waltham, Massachusetts, United States

Ownership: Private
Employees: ~50
Development stage: Other

Overview

Faber Daeufer & Itrato was a boutique law firm specializing in corporate and transactional counsel primarily serving clients in the drug development/life sciences sector—including biotech startups through commercial-stage pharma firms—as well as investors and academic institutions. Their expertise spanned venture finance deals through complex licensing/R&D agreements that underpin innovation pipelines across therapeutics/devices/research tools sectors. In June 2025 they merged with global law firm Crowell & Moring LLP to form "Crowell Life Sciences," expanding their reach while maintaining their specialized focus on supporting growth at every stage within the health innovation ecosystem.

Industry: Consulting

Partnerships

Crowell Life Sciences (Crowell & Moring LLP)

Beyond the preview

Go deeper on Faber Daeufer & Itrato.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Faber Daeufer & Itrato.

Explore the full profile